Harald Pedersen

Harald Pedersen was a Danish chemist and industrialist who co-founded Novo Terapeutisk Laboratorium in 1925. His defining moment was the recognition that the future of insulin production lay in industrial-scale fermentation and purification processes, rather than small-scale laboratory extraction. His decision to invest heavily in chemical engineering and process optimization ultimately created one of the world's largest biological manufacturing platforms.

Harald Pedersen was a Danish chemist and business executive who served as the CEO of Novo Terapeutisk Laboratorium from its founding in 1925 until the 1950s. He was the primary architect of Novo's early manufacturing strategy, focusing on industrial-scale production of insulin and other biological products. Pedersen's career in chemistry spanned over four decades, during which he held various leadership positions in research and operations. His leadership style was characterized by a focus on scientific rigor and process efficiency, qualities that were essential in navigating the complex challenges of large-scale biologics manufacturing. After stepping down as CEO, Pedersen remained active in the company as a board member and advisor, serving on the boards of several major Danish corporations. He is widely respected in Denmark for his role in creating a global biological manufacturing leader and for his commitment to maintaining the company's headquarters in Denmark.